Methods and compositions for amplified electrochemiluminescence detection
Disclosed herein are formulations, substrates, and arrays. Also disclosed herein are methods for manufacturing and using the formulations, substrates, and arrays. Also disclosed are methods for identifying peptide sequences useful for diagnosis and treatment of disorders, and methods for using the peptide sequences for diagnosis and treatment of disorders, e.g., celiac disorder. In certain embodiments, substrates and arrays comprise a porous layer for synthesis and attachment of polymers or biomolecules.
1. A method of detecting a target biomolecule, comprising
contacting a sample comprising said target biomolecule with a capture ligand, said capture ligand being immobilized at a defined location on a substrate and capable of specifically binding said target biomolecule thereby immobilizing said target biomolecule at said defined location on said substrate;
contacting said immobilized target biomolecule with a detection ligand, said detection ligand comprising an antibody or antigen-binding fragment capable of specifically binding to said immobilized target biomolecule and wherein said antibody or antigen binding fragment is conjugated to a peroxidase enzyme, thereby forming an immobilized target biomolecule-detection ligand complex;
contacting said complex with a tagging solution comprising a plurality of AECL tags under conditions that promote covalent binding of said plurality of AECL tags to said complex, wherein each of the AECL tags comprises a ruthenium metal chelate and a tyramide bound to said ruthenium metal chelate, and wherein said tagging solution further comprises hydrogen peroxide;
washing said substrate to remove unbound AECL tags from said substrate;
contacting said substrate with a detection solution that reacts with said bound AECL tags to generate luminescence when a voltage is applied to said defined location on said substrate, wherein said detection solution comprises tripropylamine;
applying said voltage to said defined location on said substrate; and
measuring the luminescence from said defined location on said substrate thereby detecting said target biomolecule.
2. The method of claim 1 , wherein said defined location on said substrate comprises a microarray feature or a plurality of microarray features.
3. The method of claim 2 , wherein said feature or features have a width between 50 nm and 1 um.
4. The method of claim 3 , wherein said width is between 50 nm and 100 nm.
5. The method of claim 4 , wherein said width is between 50 nm and 75 nm.
6. The method of claim 1 , wherein said capture ligand is covalently bound to said defined location on said substrate via a COOH moiety provided on said substrate.
7. The method of claim 1 , wherein said capture ligand is covalently bound to said defined location on said substrate via an NH2 moiety provided on said substrate.
8. The method of claim 1 , wherein said capture ligand and said detection ligand comprise antibodies.
9. The method of claim 1 , wherein said capture ligand comprises a peptide.
10. The method of claim 1 , wherein said capture ligand comprises a protein.
11. The method of claim 1 , wherein said target biomolecule comprises a peptide.
12. The method of claim 1 , wherein said target biomolecule comprises a protein.
13. The method of claim 12 , wherein said protein is an antibody.
14. The method of claim 1 , wherein said sample comprises, blood, serum, plasma, saliva, urine, feces or cerebrospinal fluid (CSF).
15. The method of claim 1 , wherein said sample is obtained from a human.
16. The method of claim 1 , wherein said detection ligand comprises an antibody-horseradish peroxidase conjugate.
17. The method of claim 1 , wherein at least 2, 5, 10, 20, 50, 100, 200, 500, or 1,000 AECL tags are bound to said complex.
18. The method of claim 1 , wherein said AECL tag comprises tris (bipyridine) ruthenium(II).
19. The method of claim 1 , wherein said AECL tag comprises,
wherein M n+ is Ru 2+ .
20. The method of claim 1 , wherein the method detects said target biomolecule in the sample at 1 fg/mL concentrations.